Print page
Email page
Download PDF
« Previous Release | Next Release »
NASHVILLE, Tenn., Aug 02, 2010 /PRNewswire via COMTEX News Network/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference at the Southampton Inn in Southampton, New York on Friday, August 13, 2010 at 9:20 a.m. Eastern Time.
The presentation will be simultaneously webcast and can be accessed by visiting the Investor Relations section of Cumberland Pharmaceuticals' website at www.cumberlandpharma.com. Shortly following the live webcast a replay will also be available on the Company website.
About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals Inc. is a Tennessee-based specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland markets Acetadote(R) for the treatment of acetaminophen poisoning, Caldolor(R), the first injectable treatment for pain and fever approved in the United States, and Kristalose(R), a prescription laxative. Cumberland is dedicated to providing innovative products which improve quality of care for patients.
For more information on Cumberland Pharmaceuticals, please visit the Company website at www.cumberlandpharma.com.
Contact:
Angela Novak
Investor Relations
(615) 255-0068
investors@cumberlandpharma.com
SOURCE Cumberland Pharmaceuticals Inc.
Copyright (C) 2010 PR Newswire. All rights reserved